Data Sets
Business deals in the health and wellness sector are thriving as companies work to broaden their offerings, embrace innovation, and maintain an edge in a market shaped by shifting consumer priorities. Mergers and acquisitions have emerged as a central strategy, with global conglomerates and category leaders acquiring emerging and niche wellness brands to access new demographics and align with high-growth trends such as functional nutrition, mental health, fitness tech, and holistic self-care. Strategic partnerships – whether between wellness brands and healthcare providers, fitness platforms, or high-profile athletes – are also becoming more common, leveraging trusted voices and communities to boost engagement and customer loyalty.
At the same time, private equity and venture capital firms are increasingly targeting high-potential health and wellness startups, drawn to their scalable models and disruptive approaches to preventative health, longevity, and personalized care. Cross-industry collaborations, such as alliances between wellness companies and technology innovators, are also accelerating breakthroughs in areas like wearable health monitoring, telehealth integration, and data-driven wellness programs. These deals underscore the sector’s rapid evolution and its drive to meet growing demand for solutions that blend physical, mental, and digital well-being.
With this backdrop, here is a tracker of the most recent mergers, acquisitions, and investments in the health, wellness, and fitness space …
French healthtech startup Lucis has closed an $8.5 million seed round to expand its preventive health testing platform across Europe. The round was led by General Catalyst, with participation from Y Combinator, Kima Ventures, Motier Ventures, Circle.Co, and North South Ventures.
Founded by Maxime Berthelot, Baptiste Debever, and Max Guerois, Lucis helps individuals track 180+ biomarkers, spanning cardiometabolic health, hormones, inflammation, and more, through recurring lab tests and an AI-powered dashboard. The platform delivers personalized action plans focused on five areas: nutrition, supplements, activity, sleep, and mental health.
The new funding will support Lucis’ expansion in France, the UK, Ireland, and Portugal, while growing its lab and clinical networks and advancing its AI capabilities. “Our mission is to give people clarity and control over their health, long before symptoms appear,” said CEO Maxime Berthelot.
Biologica, a new women’s wellness brand founded by Liz Zwillinger and Allbirds co-founder Joey Zwillinger, has officially launched alongside a $7 million seed round led by Addition. The brand introduces a line of science-backed, stage-specific daily essentials tailored to support women through the reproductive years, perimenopause, and postmenopause.
Investors include Hawktail (Michael Polansky), Greycroft (Katherine Power), True Beauty Ventures, Good Friends (founders of Warby Parker, Harry’s, and Flamingo), Gabrielle Bernstein, and Katherine Schwarzenegger Pratt.
Born from Liz Zwillinger’s personal experience navigating hormonal health, Biologica aims to simplify women’s wellness with targeted nutrition and one delicious daily routine. “Women’s bodies change but most products don’t,” said Zwillinger. “Biologica is here to change that.”
UK-based healthtech platform MANUAL has acquired FORMEL SKIN, Germany’s leading digital dermatology provider, in a move that signals the group’s expansion from skin health to whole-body care. The combined company aims to deliver Europe’s most advanced medical weight-loss program and build a category-defining unified health platform.
Founded in 2019, FORMEL SKIN has delivered over 2 million treatments through a digital model that blends clinical expertise with personalized care. The Berlin-based company has become a trusted leader in digital dermatology, known for its strong treatment outcomes and academic partnerships.
“This is the most important milestone in FORMEL SKIN’s journey,” said CEO Florian Semler, who will continue in his role. “Together with MANUAL, we’re ready to expand into new verticals and markets.”
Function Health, the AI-driven lab testing and health data platform, has raised $298 million in a Series B round led by Redpoint Ventures, bringing its valuation to $2.5 billion. Investors in the round include a16z, Aglaé Ventures, Battery Ventures, NFDG, and notable angels such as Allen Crabbe, Blake Griffin, and Anthony Wood.
The raise brings Function’s total funding to $350 million as it accelerates its mission to make personalized health data actionable for everyone. Founded by Jonathan Swerdlin, Function helps users track and understand their health through regular lab testing, consolidated health records, and AI-powered insights. The company also unveiled its Medical Intelligence Lab, where it’s developing a generative AI model trained by physicians to deliver tailored health guidance across lab results, doctor notes, and scan data.
“It’s not good enough to live in a world with AI and not apply it to your health,” said Swerdlin. “We’re here to help people manage their biology with the best tech available.”
Wellness tech startup Unlimitr has raised $1.1 million in seed funding from a group of Texas-based investors, valuing the company at $7 million. The funds will fuel the development of AI and analytics capabilities, expand global partnerships, and support the launch of a coach training and community engagement program. Formerly known as Health Click Away, Unlimitr was co-founded in 2020 by Ruchika Gupta and Gaurav Agarwal. Operating in over 40 countries, the platform connects 98,000 users with 5,000+ certified wellness professionals and delivers personalized health journeys powered by AI and human insight.
“What started as a personal need has evolved into a global ecosystem backed by AI, science, and compassion,” said Gupta, Unlimitr’s co-founder and CEO. “With this investment, we’re set to make Unlimitr the go-to wellness destination.”
TRIP, the world’s leading calming drinks brand, has raised $40 million in a funding round backed by celebrities including Joe Jonas, Alessandra Ambrosio, Paul Wesley, Ashley Graham, and consumer growth fund Coefficient Capital. The investment supports TRIP’s rapid U.S. expansion as the brand is projected to hit $100 million in revenue this year and $200 million by 2026. With products now available in 10,000 U.S. retail doors, including Target, Whole Foods, CVS, and Soho House, TRIP is tapping into surging demand for better-for-you beverages that support stress management and alcohol-free lifestyles.
“We created TRIP to make daily calm accessible to everyone, everywhere,” said Olivia Ferdi, CEO and founder. “This round will help us deliver a billion moments of calm while continuing to scale our community-led innovation.”
Functional wellness brand Plant People has raised an undisclosed Series A round led by global private equity firm Manna Tree, with continued backing from early investor Unilever Ventures. The deal gives Manna Tree a significant minority stake as the brand prepares to scale its clean-label supplement line and expand distribution.
Founded in 2018 by Hudson Davis-Ross and Gabe Kennedy, Plant People creates science-backed Wonder gummies formulated with plant-based ingredients to support sleep, stress, focus, hydration, beauty, and weight management. The brand has become a category leader at Whole Foods, Sprouts, and Erewhon, with strong DTC traction and top-rated reviews on Amazon.
“We’ve built a profitable, purpose-led brand with minimal capital – and now, with Manna Tree’s partnership, we’re ready to grow faster and smarter,” said CEO Hudson Davis-Ross.
Premium supplements brand Cymbiotika has raised $25 million in fresh funding, bringing on high-profile investors from the sports and music industries as it scales its clinically tested, high-absorption formulations. Known for its liquid and liposomal gel formats, Cymbiotika has sold over 100 million single-serve packets to date and is now expanding distribution through a new deal with Target.
The San Diego-based brand offers a wide range of bioavailable supplements – from Irish sea moss to magnesium complex – designed to support energy, cognition, beauty, and daily performance. The funding positions Cymbiotika to surpass $150 million in sales in 2025.
Sandbar, a wearable tech startup founded by ex-Meta engineers, has raised $13 million to launch Stream, a minimalist, voice-controlled smart ring designed to make human-computer interaction feel as natural as thought. The round was led by True Ventures, with participation from Upfront Ventures and Betaworks.
Worn on the dominant index finger, Stream transcribes whispers with high accuracy, offers gesture-based controls, and syncs with a companion iOS app. A Pro tier unlocks deeper features for $10/month, while preorders start at $249. “We’re building a bridge between thought and action,” said CEO Mina Fahmi. “Stream listens only when you want it to and responds like a trusted companion.”
Midlands-founded health-tech startup Rem3dy Health has raised £1.4 million to fuel international growth and advance R&D for its flagship personalised nutrition brand, Nourished. The round was led by Amsterdam-based Borski Fund (£900K) and Future Planet Capital Regional (£500K). Founded by Melissa Snover, Rem3dy Health uses patented 3D printing technology to create custom, stackable nutrition gummies tailored to individual health needs, positioning Nourished at the forefront of preventative wellness.
“This is about more than capital, it’s a signal that regionally based, high-growth companies can attract global backing when given the right platform,” said Snover.
Recess, the pioneer in relaxation beverages, has closed a $30 million Series B round led by CAVU Consumer Partners, with participation from Rocana, Midnight Ventures, Torch Capital, Doehler Ventures, KAS Venture Partners, Vanquish, and Craig Kallman. The funding will support team growth, retail expansion, and increased marketing as Recess positions itself as the go-to brand for functional calm.
Alongside the raise, Recess appointed Kyle Thomas, former Global Chief Commercial Officer at Nutrabolt (C4 Energy, Bloom), as President and Co-CEO, joining founder Ben Witte to lead the company’s next growth phase. Recess, known for its Mood and Zero Proof beverage lines, is redefining what modern relaxation looks like for overstimulated consumers. Backer CAVU, whose recent success includes poppi’s $1.95B Pepsi acquisition, sees Recess as a defining brand in the emerging $25B+ counter-stimulation market.
“Recess isn’t about powering through the day, it’s about being more mindful within it,” said Jared Jacobs, Partner at CAVU. “We believe Recess is building the next household name in mental wellness.”
Sweatpals, a platform reimagining social connection through wellness and fitness, has raised $12 million in seed funding to expand its fitness-focused social network. The round was led by Patron and a16z speedrun, with participation from HartBeat Ventures, Max Mullen (Instacart), WndrCo, Pear, Antler, and Deb Liu. This brings the company’s total funding to $17.2 million.
Founded in 2022 by Salar Shahini and Mandi Zhou, Sweatpals helps users discover, join, and host local fitness events, transforming workouts into community-driven experiences. The platform also offers tools that let fitness hosts monetize their events, boosting revenue by up to 30% while fostering deeper connections.
“Sweatpals uses workouts to build true communities,” said Shahini. “We’re creating infrastructure for a generation that wants real-life connection outside of nightlife, through movement and shared purpose.”
French startup Kotcha, co-founded by marathon world record holder Eliud Kipchoge, has raised €3.5 million in a round led by Racine2, with backing from True Global, Motier Ventures, and others. The funds will support European expansion, team growth, and further development of Kotcha’s AI engine.
Unlike standard apps with fixed training plans, Kotcha offers dynamic, daily-updated schedules and real-time support through four AI personas, coach, trainer, nutritionist, and analyst, trained on Kipchoge’s own team. The app provides run briefings, debriefs, and 24/7 answers to training, nutrition, and recovery questions.
“Our mission is to bring the team experience to every runner,” said CEO Ben Dupont.
Women’s wellness brand Unfabled has raised $1.7 million in new funding to support its rapid expansion across the UK, bringing its total capital raised to $3.9 million. The round was led by London-based Arāya Ventures, backed by British Business Investments, with participation from previous investors including Morgan Stanley, Exceptional Ventures, and Atomico Angels. Founded in 2021 by Forbes 30 Under 30 honouree Hannah Samano, Unfabled offers supplements targeting bloating, cramps, sleep, stress, and energy, developed through a community-led R&D approach via Unfabled Labs.
The funding coincides with a major retail milestone: Boots is rolling out Unfabled’s range to 737 stores nationwide, a 1,000% increase from its initial 50-store launch in late 2024. As a graduate of the Boots Ignite accelerator, Unfabled is one of the program’s first wellness brands to achieve national scale.
With fresh capital and retail momentum, Unfabled is doubling down on its mission to redefine women’s health with science-backed, consumer-driven innovation.
Belgian wellness brand Insentials has secured its first outside investment, welcoming French venture capital fund Eutopia and FG Bros, the Frère-Gallienne family office, as minority stakeholders. Previously self-funded, Insentials is known for its personalized, science-backed supplements tailored to women’s health. The funding will enable the brand to scale operations, expand across Europe, and deepen its commitment to personalized wellness solutions.
“This marks a new chapter for Insentials as we continue our mission to make health truly personal,” said founder and CEO Lynn De Proft.
Oura Health Oy, the Finnish company behind the popular Oura Ring, is raising $875 million in a Series E round that values the company at approximately $10.9 billion, more than double its $5 billion valuation from its Series D in December 2024, according to Bloomberg. The round could exceed $900 million and is expected to close by the end of the month.
Oura reportedly plans to use the capital to scale production, invest in product development, and drive international expansion. The company has sold 5.5 million rings to date, up from 2.5 million in mid-2024, and is on track to generate over $1 billion in revenue this year, doubling its 2024 total. Sales are forecast to surpass $1.5 billion in 2026. The raise comes alongside a $250 million credit line secured from JPMorgan, Goldman Sachs, Citigroup, and Barclays, further positioning Oura to scale as a global leader in wearable health tech.
Digital maternal health startup Lōvu Health has raised $8 million in Series A funding to enhance its AI capabilities and expand its integrated care platform. The round was led by SJF Ventures, with participation from Rogue Women’s Fund, Symphonic Capital, Emmeline Ventures, Majella Ventures, and others, bringing the company’s total funding to $14 million.
Based in Cupertino, Lōvu supports mothers and babies from conception through two years postpartum. Its platform pairs patients with pregnancy navigators, connects vitals-tracking devices to OBs, and offers mental health tools, personalized guidance, and access to third-party specialists like doulas, lactation consultants, and physical therapists.
“SJF has had a long-standing interest in maternal health, and Lōvu stood out as a win-win-win for providers, health plans, and mothers,” said Perry Clarkson, Partner at SJF Ventures.
Birmingham-based health and wellness company resbiotic has raised $14.5 million in total funding, including an $8 million Series A round led by Sororibus Capital and Biostack Ventures. Founded by Dr. C. Vivek Lal, resbiotic is known for its science-backed Gut-X Axis platform, which links gut health to whole-body outcomes. The company’s flagship product, resB Lung Support, is the first clinically tested probiotic targeting the gut–lung axis for respiratory health.
The new funding will support expansion into metabolic, women’s, and bone health, as well as retail and e-commerce scale-up and growth of its B2B formulations business.
Lisbon-based Nutrium has secured $12 million in Series A funding to expand its all-in-one corporate nutrition solution. The round was led by Vesalius Biocapital, with participation from Lince Capital, Indico Capital Partners, and Beta Capital. Nutrium connects millions of patients to a global network of over 350,000 registered dietitians across 90+ countries, offering personalized meal planning, chronic disease management, and preventive care. The funding comes as employers seek sustainable, non-pharmaceutical strategies to curb rising healthcare costs amid increasing obesity rates and demand for GLP-1 medications.
“Nutrition has become a business priority,” said CEO and Co-founder André Santos. “This funding allows us to scale our impact and deliver measurable outcomes for companies and their people worldwide.”
Longevity-focused health tech company Fountain Life has secured $18 million in Series B funding to accelerate the expansion of its preventative care centers and early detection services. The round was led by EOS Ventures and included participation from existing board members, bringing the company’s total funding to $108 million. Co-founded by Dr. William Kapp, Dr. Peter Diamandis, and Tony Robbins, Fountain Life uses advanced diagnostics, including blood tests and full-body scans, to monitor over 100 biomarkers and detect chronic conditions at their earliest, often asymptomatic stages.
Fountain Life offers annual membership plans starting at $10,500, with quarterly testing and results delivered through an AI-powered app. The company also aims to improve affordability by training external medical providers in its preventative care model. The new capital will support the opening of additional centers in Houston, Los Angeles, and Miami, adding to its existing locations in Naples, Westchester, Orlando, and Dallas.
“Our mission is to shift healthcare from reactive to proactive,” said CEO Dr. William Kapp. “With this funding, we’re expanding access to cutting-edge diagnostics and personalized health optimization.”
THG Group, owner of MyProtein, has agreed to sell its Claremont Ingredients business to international flavour specialist Nactarome for £103 million. Claremont, a UK-based flavor manufacturing and development lab serving sports nutrition, bakery, and beverage sectors, joined THG Nutrition in 2020 to accelerate MyProtein’s global licensing and new product development efforts. THG said the deal delivers a “significant return” through cash generation and sale proceeds, while preserving a long-term supply relationship with Nactarome.
“Claremont has been a huge success, building MyProtein’s global licensing franchise from a standing start,” said THG CEO Matthew Moulding. “The level of interest reflects the quality of the business and the value embedded across THG’s portfolio.” Nactarome, majority-owned by TA Associates, operates in nine European countries and said the deal marks its entry into sports nutrition, complementing its flavour and ingredient expertise.
U.K.-based Ditto Daily has raised £1.35 million ($1.72 million) in pre-seed funding to expand its science-backed Cycle Supplement for menstrual symptoms. Led by Eka Ventures with participation from Jean-Baptiste Wautier, the round will fund clinical research, product innovation, and channel growth. Co-developed with Dr. Anita Mitra, the supplement uses “beadlet-in-oil” nutrient delivery for enhanced absorption and has seen strong uptake since its launch four months ago. A recent clinical trial showed 88% of participants reported reduced symptom severity.
“For too long, there has been a huge disconnect between what science understands and the solutions available,” said founder and nutrition scientist Alice van der Schoot. “This funding allows us to accelerate our research and deliver more evidence-based solutions to the billions of women who need them.”
UK-based fertility wellness startup The OVA Co has raised over $1 million in a pre-seed round led by ERA VC, with participation from Ventures Together, Syndicate Room, and a roster of prominent angel investors. The round will support the brand’s expansion into Ireland, retail growth, and deeper retail partnerships across 800+ locations including Boots and Sainsbury’s. Founded just seven months ago by former Net-A-Porter executives Danielle Fox-Thomas and Kat Lestage, The OVA Co offers fertility supplements for both egg and sperm health, combining clinical science with consumer-friendly design. The brand is part of Google’s high-growth business program and aims to bring empathy and transparency to a historically clinical category.
“The fertility aisle hasn’t caught up with how people are actually trying to conceive,” said Lestage. “We’re building a smarter, more inclusive approach to fertility support.”
Othership, the immersive wellness brand blending sauna, cold plunge, and breathwork, has closed an $8.5 million SAFE note to fuel its New York City expansion. The round includes strategic backing from Rocana Ventures, Vine Ventures, Winklevoss Capital, Blake Mycoskie, Kerry Washington, NBA star Bradley Beal, and Devon Lévesque. CEO Robbie Bent clarified that reports citing an $11.3 million raise were inaccurate.
Following the success of its Flatiron location, Othership will open a new Williamsburg club this fall, with a 13,000-square-foot flagship to follow. The upcoming space will double the size of its current offering and introduce a “bathing wing” with steam rooms, warm pools, 1:1 emotional therapies, and expanded class programming.
“We’re evolving to meet member needs,” said Bent. “There’s a natural opportunity to bring emotional wellness into the traditional bathhouse model.”
Arketa, an AI-driven platform for boutique fitness and wellness studios, has raised $15 million in Series A funding led by Inspired Capital, with participation from First Round, Y Combinator, and Amity. The funding will fuel product innovation and market expansion as the boutique fitness industry, projected to reach $80 billion by 2029, continues to surge.
Founded to modernize operations for fitness entrepreneurs, Arketa equips studios with enterprise-grade tools including automated customer support, intelligent booking and pricing, and built-in marketing automation. The platform is designed to help small and mid-sized businesses scale while offering personalized, tech-enabled wellness experiences.
“As a certified yoga instructor, I saw how outdated systems held back studios,” said Co-founder and CEO Rachel Lea Fishman. “Arketa gives them the tools they need to grow, thrive, and create stronger community connections.” Inspired Capital’s Chris Brown added, “Arketa represents the future of vertical SaaS, platforms that not only solve core needs like booking and payments, but evolve into the operating system for entire industries.”